Suppr超能文献

灌注肺闪烁显像对因肺气肿和肺纤维化接受单肺移植患者的预后价值。

The prognostic value of perfusion lung scintigraphy in patients who underwent single-lung transplantation for emphysema and pulmonary fibrosis.

作者信息

Hardoff R, Steinmetz A P, Krausz Y, Bar-Sever Z, Liani M, Kramer M R

机构信息

Department of Nuclear Medicine and Institute of Pulmonology, Rabin Medical Center, Petach Tikva, Israel.

出版信息

J Nucl Med. 2000 Nov;41(11):1771-6.

Abstract

UNLABELLED

The objective of this study was to evaluate the role of quantitative perfusion lung scintigraphy (QPLS) in predicting the development of chronic rejection in patients who underwent single-lung transplantation.

METHODS

Eighteen patients (15 men, 3 women; age range, 41-60 y; mean age, 54.6+/-6.0 y) who underwent single-lung transplantation for emphysema (n = 14) or pulmonary fibrosis (n = 4) were studied. Patients were evaluated using QPLS and pulmonary function tests before surgery and at 1-3 mo and 1-3 y after transplantation. Relative perfusion of the transplanted lung was calculated from standard perfusion lung scintigrams. Values for forced expiratory volume in the first second (FEV1) were obtained from lung function tests at the same time points. The maximal and minimal relative perfusion and FEV1 values in the early (1-3 mo) and late (1-3 y) follow-up periods were identified for each patient. Receiver operating curve (ROC) analysis was performed on all parameters.

RESULTS

In total, 82 lung scans were performed (mean, 4.8+/-1.55 per patient) and 484 FEV1 test determinations were obtained (mean, 30.0+/-15.6 per patient) during a follow-up period ranging from 8 to 84 mo (mean, 39.6+/-19.3 mo). In 7 of the 18 patients, chronic rejection developed, whereas 11 patients had a favorable outcome. No significant difference was found in the number of complications (acute rejection and infection episodes) between patients with a favorable outcome and patients with chronic rejection, up to 1 y after transplantation. At 1-3 mo, minimal relative perfusion values were 67.1%+/-12.2% in the favorable outcome group and 50.8%+/-9.6% in the chronic rejection group (P = 0.02). Before surgery and at 1-3 y, minimal relative perfusion was not significantly different between the 2 groups. The difference in maximal relative perfusion at 1-3 y was marginally significant, with 76.5%+/-8.9% in the favorable group and 64.3%+/-15.0% in the chronic rejection group (P = 0.051). FEV1 values were not significantly different preoperatively and 1-3 mo after surgery between the chronic rejection and the favorable outcome groups. Late in the follow-up period (1-3 y), FEV1 values in the chronic rejection and favorable outcome groups were 35.6%+/-7.9% and 56.9%+/-13.6%, respectively (P = 0.002). ROC analysis of minimal relative perfusion at 1-3 mo identified a threshold of 57% under which the sensitivity and specificity for chronic rejection were 83% and 88%, respectively. Minimal FEV1 for the same period identified a threshold of 48% under which the sensitivity and the specificity were 80% and 67%, respectively.

CONCLUSION

QPLS early after transplantation in our patients predicted the development of chronic rejection in patients with single-lung transplantation for emphysema and pulmonary fibrosis, whereas surgical complications, acute rejection, infection episodes, and lung function tests did not predict the outcome. This early prediction could not be obtained from lung function tests performed at the same time.

摘要

未标注

本研究的目的是评估定量灌注肺闪烁扫描(QPLS)在预测接受单肺移植患者慢性排斥反应发生中的作用。

方法

对18例接受单肺移植的患者进行研究,其中男性15例,女性3例;年龄范围41 - 60岁,平均年龄54.6±6.0岁。这些患者因肺气肿(n = 14)或肺纤维化(n = 4)接受单肺移植。在手术前、移植后1 - 3个月和1 - 3年,使用QPLS和肺功能测试对患者进行评估。从标准灌注肺闪烁扫描图计算移植肺的相对灌注。在相同时间点从肺功能测试中获取第一秒用力呼气量(FEV1)值。确定每位患者在早期(1 - 3个月)和晚期(1 - 3年)随访期间的最大和最小相对灌注以及FEV1值。对所有参数进行受试者操作特征曲线(ROC)分析。

结果

在8至84个月(平均39.6±19.3个月)的随访期间,共进行了82次肺部扫描(平均每位患者4.8±1.55次),获得了484次FEV1测试测定值(平均每位患者30.0±15.6次)。18例患者中有7例发生慢性排斥反应,而11例患者预后良好。在移植后1年内,预后良好的患者与发生慢性排斥反应的患者之间并发症(急性排斥反应和感染发作)的数量没有显著差异。在1 - 3个月时,预后良好组的最小相对灌注值为67.1%±12.2%,慢性排斥反应组为50.8%±9.6%(P = 0.02)。手术前和1 - 3年时,两组之间的最小相对灌注没有显著差异。1 - 3年时最大相对灌注的差异边缘显著,预后良好组为76.5%±8.9%,慢性排斥反应组为64.3%±15.0%(P = 0.051)。慢性排斥反应组和预后良好组在术前和术后1 - 3个月时FEV1值没有显著差异。在随访后期(1 - 3年),慢性排斥反应组和预后良好组的FEV1值分别为35.6%±7.9%和56.9%±13.6%(P = 0.002)。对1 - 3个月时最小相对灌注的ROC分析确定阈值为57%,低于该阈值时慢性排斥反应的敏感性和特异性分别为83%和88%。同期最小FEV1确定阈值为48%,低于该阈值时敏感性和特异性分别为80%和67%。

结论

在我们的患者中,移植后早期的QPLS可预测因肺气肿和肺纤维化接受单肺移植患者慢性排斥反应的发生,而手术并发症、急性排斥反应、感染发作和肺功能测试均不能预测结果。同时进行的肺功能测试无法获得这种早期预测。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验